Anderson Cooper, the CNN anchor, earned praised in the liberal media on Monday after he smirked and called Mike Lindell, the CEO of MyPillow, a “snake oil salesman” over his recent praise for the experimental botanical extraction called oleandrin as a potential cure for COVID-19.
FOLLOW TODD STARNES ON TWITTER
Cooper, whose medical expertise comes from standing next to Dr. Sanjay Gupta at cocktail parties, was even more Vanderbilt smug than usual during the interview with Lindell. The founder of MyPillow has been on the receiving end of criticism from the liberal media after he committed a mortal sin: He praised God and President Trump (In the same day!).
Lindell praised the extract’s effectiveness and Cooper said, “You could be in the Old West standing on a box telling people to drink your amazing elixir that there’s no proof.”
Lindell responded, “I do what Jesus tells me to do and I give the glory to God.”
Lindell, who is wealthy, asked Cooper why he would risk his reputation to push the possible cure and Cooper responded, “You don’t have a great reputation.”
Cooper cited a lawsuit that was settled in California and the recent ‘F’ the company received from the Better Business Bureau from Minnesota. Lindell said he had been a candidate for the bureau’s top honor until he became vocal in his support for Trump.
TODD STARNES’ NEW BOOK: “Culture Jihad: How to Stop the Left From Killing a Nation.”
“As soon as I went all in for the president the Better Business Bureau lowered me from an A+ to an F,” he said.
Cooper mocked him in his snarky voice, “That’s just sad. That’s sad.”
LOU HOLTZ TELLS TODD STARNES HE WANTS COLLEGE FOOTBALL SEASON TO BE PLAYED
Cooper capped off the conversation by accusing Lindell of hypocrisy, saying that it is “extraordinary” that a person who proclaims his faith is willing to lie with such ease.
Axios reported that Trump promoted oleandrin during a recent meeting in the Oval Office, which was “embraced” by Dr. Ben Carson, the head of the Housing and Urban Development secretary, and Lindell. The report said that Lindell has recently taken a financial stake in the company.
The report indicated that oleandrin has been tested on humans and is in the process of being peer-reviewed. Lindell told Axios that Trump has indicated that the FDA will be approving it.